Search

everythinglearnresearchcommunity

for

Search:↓

Talquetamab may cause hair loss and skin issues.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Both treatments for alopecia areata showed similar modest effectiveness.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.

Clofazimine may be effective for treating ashy dermatosis.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Substances from dental stem cells might help treat hair loss.

White hair follicles in vitiligo have fewer and less functional melanocytes.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Extracts improve hair growth in alopecia.